Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study.
Eur J Cancer
; 51(4): 473-481, 2015 Mar.
Article
de En
| MEDLINE
| ID: mdl-25637137
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs colorectales
/
Protocoles de polychimiothérapie antinéoplasique
Type d'étude:
Guideline
Limites:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Langue:
En
Journal:
Eur J Cancer
Année:
2015
Type de document:
Article